MEDI

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease - 10/11 - 10:00 AM ET

MedImmune licenses reverse genetics technology to Biken - 09/30 - 09:50 AM ET

Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors - 09/03 - 08:00 AM ET

Key Patent-Law Decisions' Impact to Be Covered by Wolf Greenfield Webinar - 09/02 - 03:02 PM ET

PPD names new executive vice president and CMO - 07/23 - 10:53 AM ET

UK smallcap opening - Norwood Immunology up on MedImmune deal - 07/16 - 02:55 AM ET

Pinnacle signs stock purchase agreement with MedImmune - 06/27 - 05:01 AM ET

ASTRAZENECA SAYS MEDIMMUNE CEO MOTT TO STEP DOWN - 06/26 - 09:05 AM ET

Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune - 06/26 - 04:29 AM ET

Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune - 06/26 - 02:00 AM ET

DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform - 06/24 - 02:32 AM ET

DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform - 06/24 - 02:01 AM ET

Micromet and MedImmune initiate treatment in Phase II leukemia trial - 06/13 - 10:02 AM ET

MedImmune's Brian Rosen Gets Montgomery County Chamber Chairmans Award - 06/08 - 05:35 PM ET

Qualys to Host Its Security Conference - 05/14 - 03:52 PM ET

MedImmune's motavizumab found effective in Phase III RSV trial - 05/05 - 06:27 AM ET

MedImmune launches two new trials for treatment of asthma - 04/16 - 09:34 AM ET

Sun Pharma launches generic Ethyol in the U.S. - 03/31 - 06:12 AM ET

Genaera's partner MedImmune initiates Phase II asthma trial - 03/19 - 05:15 AM ET

GENAERA: DEVELOPMENT PARTNER MEDIMMUNE INITIATES PHASE IIA TRIAL OF MEDI-528 - 03/19 - 03:22 AM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index